Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert
Clinical trial NCT05070728 · TERMINATED
Trial details
- NCT number
- NCT05070728
- Sponsor
- EyePoint Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-13
- Primary completion
- 2023-04-12
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.